<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Freddy Buntoum

18+ years’ experience with expertise in Market Insights and Competitive Intelligence at major manufacturers in Medical Device and Crop Science, including 4+ years at Bioventus as a Sr. Manager, Market Insights.

Regenerative Medicine

Emerging Leaders in Regen Med: A Talk with Jointechlabs' CEO Nathan Katz

Jointechlabs – Emerging leader in point-of-care regenerative and rejuvenation medicine therapies Nathan ...

Orthobiologics

Bursting Bubbles: Q321 Joint Fluid Market Recap

Q321 results were a letdown compared to the previous quarter as COVID-19 continues to burst HA players’ ...

Top Story

Evolution is Inevitable: An Interview with Anika's Cheryl Blanchard, PhD

Cheryl Blanchard, President and CEO of Anika Therapeutics, discusses the Company’s metamorphosis from a ...

Orthopedics

The Debate Over HA Therapy: AAOS 2021

This Year’s AAOS Annual Meeting was no different--scientific bodies are still divided on the efficacy of...

Orthobiologics

The Slingshot Effect: Q121 US Orthobio Market Recap

In spite of various headwinds, a strong uptick in surgical procedures and business activities in March w...

Orthobiologics

A Smoother Road Ahead: Q121 US Joint Fluid Replacement Market Recap

The first quarter of 2021 felt like riding a car with square wheels, but ahead, the road looks smoother....

Orthobiologics

Sometimes You Win: Q420/FY20 US Joint Fluid Market Recap

Like the ball whirling around a casino roulette wheel, COVID-19 sent the US Joint Fluid Market players b...

Orthobiologics

Q420/FY20 US Orthobio Market Recap

With jockeys and their racehorses out of the gates to make up for the losses during H120, a resurge of C...

Regenerative Medicine

Trends in OrthoBiologics & Regenerative Medicine: A Surgeon's Perspective

Dr. Wasik Ashraf, an Orthopaedic Surgeon specializing in Sports Medicine, discusses trends and innovatio...

Orthopedics

A Wild COVID Roller Coaster Ride: Q220 & Q320 Soft Tissue Fixation Market Recap

Although the COVID-19 roller coaster was a tough ride in Q220, Soft Tissue Fixation was stepping out and...